BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16173048)

  • 1. Roles of osteonectin in the migration of breast cancer cells into bone.
    Campo McKnight DA; Sosnoski DM; Koblinski JE; Gay CV
    J Cell Biochem; 2006 Feb; 97(2):288-302. PubMed ID: 16173048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
    Koblinski JE; Kaplan-Singer BR; VanOsdol SJ; Wu M; Engbring JA; Wang S; Goldsmith CM; Piper JT; Vostal JG; Harms JF; Welch DR; Kleinman HK
    Cancer Res; 2005 Aug; 65(16):7370-7. PubMed ID: 16103089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant.
    Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T
    Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.
    Jacob K; Webber M; Benayahu D; Kleinman HK
    Cancer Res; 1999 Sep; 59(17):4453-7. PubMed ID: 10485497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
    Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
    Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
    Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
    Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation.
    Mastro AM; Gay CV; Welch DR; Donahue HJ; Jewell J; Mercer R; DiGirolamo D; Chislock EM; Guttridge K
    J Cell Biochem; 2004 Feb; 91(2):265-76. PubMed ID: 14743387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis.
    Wang SJ; Saadi W; Lin F; Minh-Canh Nguyen C; Li Jeon N
    Exp Cell Res; 2004 Oct; 300(1):180-9. PubMed ID: 15383325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor.
    Saidak Z; Boudot C; Abdoune R; Petit L; Brazier M; Mentaverri R; Kamel S
    Exp Cell Res; 2009 Jul; 315(12):2072-80. PubMed ID: 19285978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced motility of KGF-transfected breast cancer cells.
    Zang XP; Bullen EC; Manjeshwar S; Jupe ER; Howard EW; Pento JT
    Anticancer Res; 2006; 26(2A):961-6. PubMed ID: 16619493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
    Schabath H; Runz S; Joumaa S; Altevogt P
    J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid.
    Martin TA; Das T; Mansel RE; Jiang WG
    J Cell Biochem; 2007 May; 101(1):155-66. PubMed ID: 17243118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
    Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
    Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
    Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells.
    Cazet A; Groux-Degroote S; Teylaert B; Kwon KM; Lehoux S; Slomianny C; Kim CH; Le Bourhis X; Delannoy P
    Biol Chem; 2009 Jul; 390(7):601-9. PubMed ID: 19335207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
    Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
    Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.